Mon. 6 May 2024, 4:13pm ET
Benzinga
Earnings, Earnings Misses, News
Travere Therapeutics (NASDAQ:TVTX) reported quarterly losses of $(1.51) per share which missed the analyst consensus estimate of $(0.99) by 52.53 percent. This is a 64.13 percent decrease over losses of $(0.92) per share from the same period last year. The company reported quarterly sales of $41.374 million which missed the analyst consensus estimate of $42.847 million by 3.44 percent. This is a 33.95 percent increase over sales of $30.888 million the same period last year.